~~<i id='271AFF57E7'><strike id='271AFF57E7'><tt id='271AFF57E7'><pre id='271AFF57E7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

entertainment

author：hotspot 2025-09-28 21:56:38 - browse：34193

A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

See below for an archived chat with Helen Branswell about these issues and more.

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： 30 years of 'Listening to Prozac'

explore

hotspot

entertainment

hotspot

entertainment

hotspot

MollyFerguson/STATAnnovisBiohadmybiotechbull%^&!meterrunningredafteritmadealatechangetothedesign

WSS

ReNAgade cuts staff seven months after raising $300 million

R1 RCM gets $5.8 billion buyout offer from private equity firm

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Despite FDA concern, risk that CAR

FDA investigates CAR

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

explore

entertainment

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Diagnostic tests are hitting their mathematical limits

Alkermes shareholders re

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Moonlake's readout produced a cash windfall. Risks remain

How to pay for weight loss drugs and save Medicare

At least 13 dead in Texas as scorching temps continue

He's a Nobel laureate. Critics say he was misleading on Covid

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In utero gene editing: an explainer

hotspot

With clinical trial data readouts, here's how to spot spin

ReNAgade cuts staff seven months after raising $300 million

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Ed Silverman on new gene therapies, biosimilars, coffee, and more

FDA investigates CAR

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

entertainment

hotspot

entertainment

hotspot